USA 1-800-227-2862 (BBRAUN2)
Home > Press > Company News

Company News


Read news and press releases about B. Braun Medical Inc. (B.Braun), covering subjects ranging from products, related events, company news and more.


B. Braun Medical Achieves Two GHX 2010 Best In Class Awards

Company Recognized for Continued Market Leadership in Solutions/Nutritionals and Kits, Packs and Trays

BETHLEHEM, PA, March 30, 2010 — B. Braun Medical Inc. (B. Braun) today announced that it has received two 2010 GHX Best in Class Awards for achieving the highest year-over-year market share growth for distributed products in the Solutions/Nutritionals and Kits, Packs and Trays product categories.
B. Braun was among the 31 leading medical-surgical product manufacturers recognized by GHX in six market segments and 35 product categories, ranging from electrosurgical products to microbiology reagents. Winners were determined using GHX Market Intelligence reports that analyze national distributed sales transaction data. Best-in-Class status is determined through a combination of year-over-year market share growth and total market share through the end of 2009. The winners will be honored at the 10th Annual GHX Supply Chain Summit in Orlando, March 29-31, 2010.

“B. Braun is proud of the strong customer relationships that have increased product sales,” said Caroll H. Neubauer, Chairman and CEO of B. Braun Medical Inc. “Our success in the areas honored by GHX, as in all other product segments, is built on listening to our customers and developing high quality healthcare solutions that meet customer needs.”

This is the third consecutive year GHX awarded B. Braun its Best in Class Awards in the Solutions/Nutritionals product category.

“We are extremely pleased to honor B. Braun for its leadership in the Solutions/Nutritionals and Kits, Packs and Trays categories,” said Ed McCauley, general manager, GHX Market Intelligence. “The company’s performance proves that despite the down economy there continue to be market opportunities for manufacturers if they know where to target sales efforts.”

With information provided by 27 of the nation’s leading distributors, GHX Market Intelligence tracks and reports on more than $35.5 billion of distributed sales for medical-surgical and clinical laboratory supplies and devices. It is the only comprehensive source for accurate, detailed and timely data for the acute and alternate site healthcare markets, containing geographically relevant and competitive market share, size and average selling price reporting down to the three-digit ZIP code level.

About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B.Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services,
B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals.  For more information, call 800-227-2862, e-mail us at or visit B. Braun at

About GHX
As the business hub for healthcare, Global Healthcare Exchange, LLC (GHX) enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making.  Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B. Braun Medical Inc.; BD; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc.  For more information, visit